FDA
approval
· 2023-12-15
FDA Approved: MEPERIDINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
Summary
FDA approves Hikma Pharmaceuticals USA Inc.’s supplemental application for Meperidine Hydrochloride, approving a generic version of this opioid analgesic.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MEPERIDINE HYDROCHLORIDE (MEPERIDINE HYDROCHLORIDE)